| 000 | 01823cam a2200409 i 4500 | ||
|---|---|---|---|
| 001 | ocn933760050 | ||
| 003 | OCoLC | ||
| 005 | 20170826162408.0 | ||
| 008 | 160106s2015 dcua b f000 0 eng c | ||
| 040 |
_aSEN _beng _erda _cSEN _dSEN _dGPO _dSTF _dCOO _dOCLCO _dGPO |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 050 | 1 | 4 |
_aKF26 _b.V4 2014f |
| 074 | _a1046-A-01 | ||
| 086 | 0 | _aY 4.V 64/4:S.HRG.113-746 | |
| 099 | _aY 4.V 64/4:S.HRG.113-746 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bSenate. _bCommittee on Veterans' Affairs, _eauthor. |
|
| 245 | 1 | 0 |
_aHepatitis C and veterans : _bhearing before the Committee on Veterans' Affairs, United States Senate, One Hundred Thirteenth Congress, second session, December 3, 2014. |
| 264 | 1 |
_aWashington : _bU.S. Government Publishing Office, _c2015. |
|
| 264 | 2 |
_aWashington, DC : _bFor sale by the Superintendent of Documents, U.S. Government Publishing Office |
|
| 300 |
_aiii, 46 pages : _billustrations ; _c24 cm. |
||
| 336 | _btxt | ||
| 337 |
_bn _2rdamedia |
||
| 338 |
_bnc _2rdacarrier |
||
| 490 | 1 |
_aS. hrg. ; _v113-746 |
|
| 500 | _aShipping list no.: 2016-0125-P. | ||
| 500 | _aCRDP Project record. | ||
| 504 | _aIncludes bibliographical references. | ||
| 650 | 0 |
_aHepatitis C _xChemotherapy _zUnited States _xCosts. |
|
| 610 | 2 | 0 | _aGilead Sciences (Firm) |
| 650 | 0 |
_aVeterans _xMedical care _zUnited States. |
|
| 655 | 7 |
_aLegislative hearings. _2lcgft |
|
| 776 | 0 | 8 |
_iOnline version: _aUnited States. Congress. Senate. Committee on Veterans' Affairs. _tHepatitis C and veterans _w(OCoLC)933528332 |
| 776 | 0 | 8 |
_iMicrofiche version: _aUnited States. Congress. Senate. Committee on Veterans' Affairs. _tHepatitis C and veterans _w(OCoLC)948805053 |
| 810 | 1 |
_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v113-746. |
|
| 949 |
_aBEV _bFed Docs |
||
| 942 | _c3 | ||
| 999 |
_c265894 _d265894 |
||